Prostate cancer treatment study changing the way doctors practice

Despite menopause-like side effects, continuous hormone treatment is superior to intermittent therapy

2013-04-04

(Press-News.org) A study published today in the New England Journal of Medicine recommends a dramatic shift in the way doctors treat metastatic prostate cancer.

"These results have changed the way I treat patients," said Ian M. Thompson Jr., M.D., director of the Cancer Therapy & Research Center at The University of Texas Health Science Center at San Antonio and senior author on the international study.

Hormone therapy in hormone-sensitive prostate cancer has been shown to help extend the lives of patients, but it causes a range of unpleasant side effects in men like moodiness, hot flashes, bone loss and sexual dysfunction. To give patients relief, doctors have, in some cases, "pulsed" the therapy — giving it to men for a time and then stopping it until the signs of prostate cancer activity reappear, then starting the hormone therapy again until the cancer appears to be under control.

The study shows that the continuous therapy helps men more. Men with less advanced metastatic prostate cancer who received the "pulse" or intermittent hormone therapy died an average of two years sooner than those on continuous therapy. The study results first drew attention when they were announced last summer at the annual meeting of the American Society of Clinical Oncology.

After that, prostate cancer survivor Floyd Balter switched from pulse to continuous therapy.

"Last year Dr. Thompson told me about the study results," said Balter, 78. "I said, 'Let's do it.'"

Surviving 17 years beyond a diagnosis where he'd been given two years to live, Balter said he's determined to watch his grandchildren grow for as long as possible.

"I want to live as long as I can," he said. "I can live with the side effects. They're a pain but I can tolerate them."

In the study results, if men with more extensive disease are included in the group, survival was more modest, extended by an average of 7 months, "which is longer than any other intervention," said Dr. Thompson, director of the CTRC. Often advances in cancer treatments will only extend life by an average of two or three months, he noted.

"I can now give a patient the option of putting up with some side effects in order to spend several more months or even years with his grandchildren," Dr. Thompson said. "I can tell you they are happy to have that choice."

Also, Dr. Thompson pointed out, because of the increase in PSA testing, most men who are diagnosed with metastatic prostate cancer present with disease that is still minimal.

The study followed 1,535 men with metastatic prostate cancer for a median of almost 10 years. It was led by SWOG, an international network of research institutions. The significance of the results, adding months if not years to the lives of many men, means every physician with prostate cancer patients should take them into account, Dr. Thompson said.

### END

ELSE PRESS RELEASES FROM THIS DATE:

Study reveals that chemotherapy works in an unexpected way

2013-04-04

It's generally thought that anticancer chemotherapies work like antibiotics do, by directly killing off what's harmful. But new research published online on April 4 in the Cell Press journal Immunity shows that effective chemotherapies actually work by mobilizing the body's own immune cells to fight cancer. Researchers found that chemo-treated dying tumors secrete a factor that attracts certain immune cells, which then ingest tumor proteins and present them on their surfaces as alert signals that an invader is present. This new understanding of how chemotherapy works with ...

New genetic markers may signal who is at increased risk for Alzheimer's disease

2013-04-04

People who have a buildup of certain proteins in the brain and spinal fluid have an increased likelihood of developing Alzheimer's disease, but it's currently unclear who will develop these protein accumulations. Now researchers reporting online April 4th in the Cell Press journal Neuron have identified mutations in certain genetic regions that influence the levels of these protein accumulations. The findings may not only help identify people most at risk of developing Alzheimer's disease well before they show signs of cognitive decline, but also offer new information for ...

Bumblebees use logic to find the best flowers

2013-04-04

Scientists at Queen Mary, University of London and the Zoological Society of London (ZSL), have discovered why bees copy each other when looking for nectar – and the answer is remarkably simple. Despite their tiny brains, bees are smart enough to pick out the most attractive flowers by watching other bees and learning from their behaviour. By using simple logic, they see which coloured flowers are the most popular, and conclude that those of the same colour must also contain lots of energy-rich nectar. "Learning where to find nectar by watching others seems fantastically ...

Obesity without the health problems? There could be a way

2013-04-04

Obesity is linked to the widespread epidemics of diabetes and heart disease that plague society, but a lesser-known fact is that the weight can also lead to autoimmune disease. Now, researchers have new information about how that damaging immune response happens and how it might be stopped, published on April 4 in Cell Reports, a Cell Press publication. The key, they show, may be to block an important element known as AIM (for apoptosis inhibitor of macrophage) in the bloodstream and, ultimately, the production of antibodies that attack the self. The discovery is especially ...

On Twitter, anti-vaccination sentiments spread more easily than pro-vaccination sentiments

2013-04-04

On Twitter, a popular microblogging and social-networking service, statements about vaccines may have unexpected effects -- positive messages may backfire, according to a team of Penn State University researchers led by Marcel Salathé, an assistant professor of biology. The team tracked the pro-vaccine and anti-vaccine messages to which Twitter users were exposed and then observed how those users expressed their own sentiments about a new vaccine for combating influenza H1N1 -- a virus strain responsible for swine flu. The results, which may help health officials improve ...

Protein maintains order in the nucleus

2013-04-04

This press release is available in German. Freiburg: Two metres of DNA are packed into the cell nucleus, presumably based on a strictly defined arrangement. Researchers working with biologist Patrick Heun from the Max Planck Institute of Immunobiology and Epigenetics in Freiburg have now succeeded in explaining a phenomenon, which was first observed 40 years ago. The centromeres, namely the structures at the primary constriction of the X-shaped chromosomes, are clustered in a few specific locations in the cell nucleus. Using fruit flies as a model, the researchers ...

Shutting down DNA construction: How senescence halts growth of potential cancers

2013-04-04

Researchers from The Wistar Institute explain a new molecular mechanism behind the phenomenon of oncogene-induced senescence. By depriving the cell of the ability to make new nucleotides—the building blocks of DNA molecules—cells can suppress cancer development by forcing a damaged cell into a senescent state, where the cell remains alive yet cannot reproduce. According to the researchers, their findings may offer a new strategy to strengthen the effects of anti-cancer drugs and chemotherapies. Their results, which appear in the April 25 issue of Cell Reports (available ...

Scissor-like enzyme points toward treatment of infectious disease

2013-04-04

DALLAS – April 4, 2013 – UT Southwestern Medical Center researchers report that a pathogen annually blamed for an estimated 90 million cases of food-borne illness defeats a host's immune response by using a fat-snipping enzyme to cut off cellular communication. "Our findings provide insight into severe bacterial infectious diseases, as well as some forms of cancer, in which the attachment of fat molecules to proteins is an essential feature of the disease process," said Dr. Neal Alto, assistant professor of microbiology and senior author of the study in today's print ...

Genetic markers ID second Alzheimer's pathway

2013-04-04

Researchers at Washington University School of Medicine in St. Louis have identified a new set of genetic markers for Alzheimer's that point to a second pathway through which the disease develops. Much of the genetic research on Alzheimer's centers on amyloid-beta, a key component of brain plaques that build up in the brains of people with the disease. In the new study, the scientists identified several genes linked to the tau protein, which is found in the tangles that develop in the brain as Alzheimer's progresses and patients develop dementia. The findings may help ...

Dwarf whale survived well into Ice Age

2013-04-04

Research from New Zealand's University of Otago detailing the fossil of a dwarf baleen whale from Northern California reveals that it avoided extinction far longer than previously thought. Otago Department of Geology PhD student Robert Boessenecker has found that the fossil of the 4-5 meter long Herpetocetus, thought to be the last survivor of the primitive baleen whale family called cetotheres, may be as young as 700,000 years old. Mr Boessenecker says the previously youngest-known fossils of this whale were from the pre-Ice Age Pliocene epoch; approximately 3 million ...

Prostate cancer treatment study changing the way doctors practice

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: